Henson joins MCG as director of neuro-oncology
Henson is a neuro-oncologist with more than two decades of experience treating patients with brain tumors and other tumors of the nervous system.
Brian H. Annex, M.D., FACC, FAHA
Department Chair, Medicine
Please explore this site to look at the activities across our missions to: provide the very best and safest patient care, educate the next generation of health care professionals, and advance knowledge in medicine through basic, clinical, and translational research. In a year like no other, the DOM continued to add to its rich history of excellence in education of students, residents, and general and subspecialty fellows.
The Medical College of Georgia is the 13th oldest medical school in the US and the DOM even when facing the changes of this last has its eyes focused firmly on the future. See the activity within the 11 major divisions. See the many new hires (myself included having been here for just over one year) and programs. Contact us directly. We look forward to hearing from you.
Learn more about our Education Programs.
Learn more about becoming a patient.
Learn more about our research.
Department of Medicine
Health Sciences Campus
706-721-2941
706-721-9405
BI-5076
chevron-circle-right icon Hospital Medicine: Krisztina Nadasy, MD (10/1/20), Patricia Morissette, MD, Derek Baker, MD and Adonis Imam, MD
chevron-circle-right icon Nephrology: Ravi Mallavarapu, MD
chevron-circle-right icon Infectious Disease: Sarah Tran, MD
chevron-circle-right icon Endocrinology: Ghada Elshimy, MD and Sara Healy, MD
chevron-circle-right icon Pulmonary: Rabih Bechara, MD, FCCP and William Healy, MD
chevron-circle-right icon Hem/Onc: Girindra Raval, MD
chevron-circle-right icon Rheumatology: Hong Shi, MD
Henson is a neuro-oncologist with more than two decades of experience treating patients with brain tumors and other tumors of the nervous system.
Starting with early childhood, otherwise healthy Black people show signs of slightly diminished heart muscle strength and a slightly higher blood pressure than their white counterparts, possibly putting them on a course for early development of congestive heart failure.
Identifying more genetic mutations in an individual’s cancer enables more targeted treatment for patients. That includes finding mutations not previously associated with their cancer type, which opens the door to using drugs targeting those mutations that have traditionally been used against other cancers.
Dr. Arni Rao and his co-authors instead suggest more of a dynamic, moment in time approach using a model called the geometric mean. That model uses today’s number to predict tomorrow’s numbers.